Found 19 matching trials
Safety and Pharmacokinetics of GH002 in Healthy Volunteers
PHASE1The primary objectives of this study are to investigate the safety and seru...
Location
GH Research Clinical Trial Site
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
PHASE1The primary objective of the study is to assess the pharmacokinetics, safet...
Location
Altasciences Clinical Kansas, Inc
Personality and Drug Use
N/AThis is an observational, naturalistic study that aims to assess whether pe...
Location
Multiple Locations
Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants
PHASE1Participation in this study lasts approximately two weeks and includes thre...
Location
University Hospital Basel
Pharmacokinetics of GH001 in Healthy Volunteers
PHASE1The primary objective of this study is to investigate the serum pharmacokin...
Location
GH Research Clinical Trial Site
Phase 2 Clinical Trial of GH001 in Bipolar II Disorder
PHASE2This study is a multicenter, open-label, single-arm Phase 2 clinical trial....
Location
Investigational Site
Safety of GH001 in Healthy Volunteers
PHASE1The aim of the study is to investigate the safety of GH001 (containing 5-me...
Location
Clinical Trial Site
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
N/AThis is an observational study which does NOT directly administer a psyched...
Location
Connecticut Mental Health Center
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
PHASE1The study will evaluate safety, tolerability and PK profile of 5-MeO-DMT in...
Location
King's College London
Personality and Drug Use (PDU)
N/AThe study aims to assess whether the use of drugs relates to personality ra...
Location
Multiple Locations